GLAXOSMITHKLINE PHARMACEUTICALS LTD.
Market Cap.(`)
|
34611.35 Cr.
|
P/BV
|
19.86
|
Book Value (`)
|
102.89
|
52 Week High/Low ( ` )
|
2524/1243
|
FV/ML
|
10/1
|
P/E(X)
|
56.12
|
Book Closure
|
30/06/2023
|
EPS (`)
|
36.41
|
Div Yield (%)
|
1.57
|
(` in Crs.)
You can view the
Consolidated
Cash Flow
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 841.49 | 2475.65 | 723.10 | 647.25 | 653.97 |
| | | | | |
Net CashFlow From Operating Activities | 484.23 | 810.75 | 577.93 | 490.50 | 409.49 |
Net Cash Used In Investing Activities | 807.85 | -405.51 | 418.59 | -56.84 | -153.45 |
Net Cash Used From Financing Activities | -1543.32 | -524.24 | -696.14 | -427.62 | -358.36 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | -251.25 | -119.00 | 300.38 | 6.03 | -102.33 |
Cash And Cash Equivalents Begin of Year | 286.19 | 405.19 | 104.81 | 98.78 | 201.10 |
Cash And Cash Equivalents End Of Year | 34.94 | 286.19 | 405.19 | 104.81 | 98.78 |